GxMed Nordic ApS: Financial statements 2017
CVR: 37089842
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GxMed Nordic ApS (CVR 37089842) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -505,914 and a net result of DKK -1,106,996. Equity in the 2017 report amounted to DKK 863,466. The solvency ratio was 25.2%.
- Gross Profit
- DKK -505,914
- Profit/Loss
- DKK -1,106,996
- Equity
- DKK 863,466
- Total Assets
- DKK 3,422,529
Official annual report
Keep an eye on GxMed Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of September 4, 2017, Hans Henrik Raith has joined the board of directors of GxMed Nordic ApS.
As of September 4, 2017, Michael Winstrøm has joined the board of directors of GxMed Nordic ApS.
As of September 4, 2017, Michael Winstrøm has stepped down as director of GxMed Nordic ApS.
GxMed Nordic ApS has published its interim report for the period September 11, 2015 to December 31, 2016.
About GxMed Nordic ApS
GxMed Nordic ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GxMed Nordic IVS. The company is owned by HHR HOLDING A/S. The company has 1 employee (2020). In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024.